TROPION-Lung10: a phase 3 study of datopotamab deruxtecan and rilvegostomig in patients with treatment-naïve locally advanced or metastatic nonsquamous non-small cell lung cancer with high PD-L1 expression and without actionable genomic alterations

Thomas Newsom-Davis, Barbara Melosky, Rebecca S. Heist, Shun Lu, Giulia Pasello, Xiwei Chen, Marta Stachowiak, Pavlo Lyfar, Alessandra Forcina, Suresh S. Ramalingam · 2026

Read TROPION-Lung10: a phase 3 study of datopotamab deruxtecan and rilvegostomig in patients with treatment-naïve locally advanced or metastatic nonsquamous non-small cell lung cancer with high PD-L1 expression and without actionable genomic alterations by Thomas Newsom-Davis, Barbara Melosky, Rebecca S. Heist, Shun Lu, Giulia Pasello, Xiwei Chen, Marta Stachowiak, Pavlo Lyfar, Alessandra Forcina, Suresh S. Ramalingam (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12883807.txt.

Description

Thomas Newsom-Davis and co-authors lay out a phase three trial of a two-drug first treatment for advanced lung cancer in this 2025 paper. The patients have nonsquamous tumors with high PD-L1 levels and no targetable gene faults. Standard immunotherapy helps many, but some resist it from the start.

About six hundred seventy-five adults will be assigned to a drug pair, one drug alone, or the standard drug. The pair joins an antibody-drug conjugate aimed at a tumor surface protein with a two-target immune antibody. Main measures are how long the cancer stays controlled and overall survival in a biomarker-defined group. Response rates, patient reports, and safety are also tracked. The trial is registered and recruiting across many centers.

Catalog record

CREATORThomas Newsom-Davis, Barbara Melosky, Rebecca S. Heist, Shun Lu, Giulia Pasello, Xiwei Chen, Marta Stachowiak, Pavlo Lyfar, Alessandra Forcina, Suresh S. Ramalingam
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE29 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12883807

Browse the full library · About the Tower of Babel